Clinical Proteomics
Clinical Proteomics is a journal indexed in SJR in Molecular Biology and Molecular Medicine with an H index of 45. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 1890 €. The scope of the journal is focused on translational proteomics, molecular medicine. It has an SJR impact factor of 0,962 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,962.
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
0,962
H-index
45
Docs (year)
69
Docs 3y
133
Total refs
3775
Cites 3y
427
Citable 3y
128
Cites/Doc 2y
3.12
Ref/Doc
54.71
Immediate OA
1890 €
Embargoed OA
NPD
Non OA / Submission
- €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Antibody-based tissue profiling as a tool for clinical proteomics
View moreWill Cancer Proteomics Suffer from Premature Death?
View moreComparative analysis of human sperm glycocalyx from different freezability ejaculates by lectin microarray and identification of ABA as sperm freezability biomarker
View moreClinical proteomics of enervated neurons
View moreClinical proteomic analysis of scrub typhus infection
View moreCancer Site-Specific Isoforms of ENOX2 (tNOX), A Cancer-Specific Cell Surface Oxidase
View moreCancer proteomics
View moreCancer Biomarker Discovery via Targeted Profiling of Multiclass Tumor Tissue-Derived Proteomes
View moreBlood-sampling collection prior to surgery may have a significant influence upon biomarker concentrations measured
View moreBioinformatics for Comparative Proteomics
View moreApplication of sector protein microarrays to clinical samples
View moreApplication of quantitative proteomics to the integrated analysis of the ubiquitylated and global proteomes of xenograft tumor tissues
View moreAntiproliferative heparan sulfate inhibiting hyaluronan and transforming growth factor-beta expression in human lung fibroblast cells
View more18O Labeling for a Quantitative Proteomic Analysis of Glycoproteins in Hepatocellular Carcinoma
View moreAnalysis of serum protein glycosylation by a differential lectin immunosorbant assay (dLISA)
View moreAltered proteome profiles in maternal plasma in pregnancies with fetal growth restriction
View moreAffinity depletion versus relative protein enrichment: a side-by-side comparison of two major strategies for increasing human cerebrospinal fluid proteome coverage
View moreAdvances in mass spectrometry-based clinical biomarker discovery
View moreAdiponectin Receptor-1 C-Terminal Fragment (CTF) in Plasma: Putative Biomarker for Diabetes
View moreAberrant Mucin5B expression in lung adenocarcinomas detected by iTRAQ labeling quantitative proteomics and immunohistochemistry
View moreA two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer
View moreA new enzyme-linked immunosorbent assay (ELISA) for human free and bound kallikrein 9
View moreA multiplex platform for the identification of ovarian cancer biomarkers
View moreA Multi-feature Reproducibility Assessment of Mass Spectral Data in Clinical Proteomic Studies
View more